Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review

被引：0
|
作者：
Vincent Dochez
Hélène Caillon
Edouard Vaucel
Jérôme Dimet
Norbert Winer
Guillaume Ducarme
机构：
[1] CHU de Nantes,Service de Gynécologie
[2] CHU de Nantes,Obstétrique
[3] Centre Hospitalier Départemental Vendée,Service de Biochimie
[4] Centre Hospitalier Départemental Vendée,Centre de recherche clinique
来源：
Journal of Ovarian Research | / 12卷
关键词：
HE4; CA125; ROMA; RMI; Ovarian cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Ovarian cancer is the 5th leading cause of death for women with cancer worldwide. In more than 70% of cases, it is only diagnosed at an advanced stage. Our study aims to give an update on the biological markers for diagnosing ovarian cancer, specifically HE4, CA 125, RMI and ROMA algorithms.
引用
收藏
相关论文
共 50 条
  • [31] HE4 combined with CA125: favorable screening tool for ovarian cancer
    Nasrin Ghasemi
    Samira Ghobadzadeh
    Mahnaz Zahraei
    Hemn Mohammadpour
    Salahadin Bahrami
    Mohammad Bakhshi ganje
    Shokoh Rajabi
    Medical Oncology, 2014, 31
  • [32] Diagnostic and Prognostic Significance of CA125 and HE4 in Ovarian Cancer Patients
    Bandiera, E.
    Romani, C.
    Specchia, C.
    Zanotti, L.
    Belloli, S.
    Bignotti, E.
    Tassi, R. A.
    Tognon, G.
    Pecorelli, S.
    Ravaggi, A.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S539 - S539
  • [33] HE4 combined with CA125: favorable screening tool for ovarian cancer
    Ghasemi, Nasrin
    Ghobadzadeh, Samira
    Zahraei, Mahnaz
    Mohammadpour, Hemn
    Bahrami, Salahadin
    Ganje, Mohammad Bakhshi
    Rajabi, Shokoh
    MEDICAL ONCOLOGY, 2014, 31 (01)
  • [34] Urine CA125 and HE4 for the Detection of Ovarian Cancer in Symptomatic Women
    Barr, Chloe E.
    Njoku, Kelechi
    Owens, Gemma L.
    Crosbie, Emma J.
    CANCERS, 2023, 15 (04)
  • [35] Assessment of Diagnostic Values among CA-125, RMI, HE4, and ROMA for Cancer Prediction in Women with Nonfunctional Ovarian Cysts
    Oranratanaphan, Shina
    Wanishpongpan, Sinee
    Termrungruanglert, Wichai
    Triratanachat, Surang
    OBSTETRICS AND GYNECOLOGY INTERNATIONAL, 2018, 2018
  • [36] A Survey on the Role of Cancer Antigen 125 (CA125), Human Epididymis Protein 4 (HE4), Risk of Ovarian Malignancy Algorithm (ROMA), and Risk of Malignancy Index (RMI) in Pelvic Mass
    Karimi-Zarchi, Mojgan
    Behtash, Nadereh
    Mousavi, Azamsadat
    Maghami, Fazemeh Ghaem
    Gilani, Mitra Moddares
    Chiti, Zohreh
    Barouti, Esmat
    Sheikhpour, Elnaz
    Javaheri, Atiyeh
    INTERNATIONAL JOURNAL OF CANCER MANAGEMENT, 2018, 11 (12)
  • [37] Significance of HE4 estimation in comparison with CA125 in diagnosis of ovarian cancer and assessment of treatment response
    Elham O Hamed
    Hydi Ahmed
    Osama B Sedeek
    Abeer M Mohammed
    Ali A Abd-Alla
    Hazem M Abdel Ghaffar
    Diagnostic Pathology, 8
  • [38] Meta-analysis of the value of CA125 combined with HE4 in the diagnosis of recurrent ovarian cancer
    Yang, Weiwei
    Ding, Yiling
    WIENER KLINISCHE WOCHENSCHRIFT, 2024, 136 : S395 - S395
  • [39] HE4 AND CA125 IN BENIGNANDMALIGNANTDISEASES
    Kirschenhofer, A.
    Lenhard, M.
    Hertlein, L.
    Fuerst, S.
    Mayr, D.
    Nagel, D.
    Hofmann, K.
    Krocker, K.
    Burges, A.
    Lorenz, S.
    Stieber, P.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 : S253 - S253
  • [40] The clinical value of the combined detection of sEGFR, CA125 and HE4 for epithelial ovarian cancer diagnosis
    Li, Y.
    Wang, Z. -C
    Luo, L.
    Mu, C. -Y.
    Xu, J.
    Feng, Q.
    Li, S. -B.
    Gu, B.
    Ma, P.
    Lan, T.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (02) : 604 - 610
12345